Swiss-based, formerly Bruker AG - split on the 5th October 2001 into the groups: Bruker Daltonics (Mass spectroscopy), Bruker Optics (Infrared spectroscopy), Bruker AXS (X-ray spectroscopy) and Bruker BioSpin (The largest part, the NMR business core, the EPR and the Tomography activities).
Product Lines:

Texas-based university research group. Current projects include: 'Multi-Modal Molecular Imaging Agents' or 'Micro-Fluidics and Nanosensing'. For example, the research group is evaluating Ln-PK-11195 as a bimodal imaging contrast agent for brain cancer detection by MRI and fluorescence.
Please see their Current Projects Abstracts for complete coverage.

The France-based Guerbet Group is highly specialized in contrast media for medical imaging. Its strategic goal is to be a key player in this market. Products include Dotarem (Magnetic Resonance Imaging) and Xenetix (X-ray Imaging).

MRI Contrast Agents:

The Germany-based pharmaceutical company is the result of the take-over of Schering AG by Bayer AG in 2006. The Bayer Schering Pharma AG is part of the Bayer HealthCare AG, which represents the pharmaceutical part of the Bayer Group. Activities of the Bayer Schering Pharma AG are Diagnostic Imaging, Hematology and Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. The diagnostic imaging part's contrast agents for MRI, x-ray and computed tomography are 'world-market leaders'.

MRI Contrast Agents:

The principal activity of this Japan-based Group, is to manufacture and sell diagnostic substances and reagents. The Group's other activities include wholesale of reagents and analysis equipment. The Group has one consolidated subsidiary located in Japan. Diagnostic substances and reagents accounted for 83% of fiscal 2002 revenues; medical equipment, 12% and blood vessel contrast mediums, 5%. Eiken Chemical Co., Ltd. distributes Feridex®.